Atorvastatin EP Impurity C Sodium salt
| VS CAT No | VS-A037086 |
| CAS No | 1807481-00-0 |
| Mol.F. | C33H34F2N2O5 : Na |
| Mol.Wt. | 576.6 : 23.0 |
| Inv. Status | Custom Synthesis |
| Rel. CAS No | 693793-53-2 (Ca salt) ; 693794-20-6 (free base) |
Chemical Name: (3R,5R)-7-[2,3-bis(4-fluorophenyl)-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid Sodium salt (as per EP);Sodium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (as per USP)
Synonym: Atorvastatin USP Related Compound C ; fluoroatorvastatin (EP)
Shipping Temperature: Ambient
Country of Origin: India
Smiles: O=C(C(C(C1=CC=C(F)C=C1)=C(C2=CC=C(F)C=C2)N3CC[C@@H](O)C[C@@H](O)CC(O)=O)=C3C(C)C)NC4=CC=CC=C4.[Na]
Atorvastatin EP Impurity C Sodium salt is chemically (3R,5R)-7-[2,3-bis(4-fluorophenyl)-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid Sodium salt (as per EP);Sodium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (as per USP). It is also known as Atorvastatin USP Related Compound C ; fluoroatorvastatin (EP). Atorvastatin EP Impurity C Sodium salt is supplied with detailed characterization data compliant with regulatory guideline. Atorvastatin EP Impurity C Sodium salt can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atorvastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.